Publication: Austin American-Statesman
Texas Oncology has enrolled patients in an innovative stage 3 clinical trial testing an mRNA vaccine for melanoma treatment. Jeff Yorio, M.D., Texas Oncology-Austin Central, shared how the melanoma vaccine is created, what results are expected and what the trial could mean for the future of melanoma treatment.
Click here to read the full story.